Clinical Trial Update: Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of capecitabine plus irinotecan followed by capecitabine and radiation for locally advanced rectal cancer has been terminated; results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Gabi Chiorean, MD | Conditions: Rectal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2016-06-06